Speakers

Jo Brewer

VP, Allogeneic Research

Adaptimmune

Anthony Colenburg

Director of Quality

Adicet Bio

Peter Flynn

CTO

Artiva Biotherapeutics

Blake Aftab

VP, Preclinical & Translational Science

Atara Biotherapeutics

Manny Duenas

VP, Head of Global Market Access

Atara Biotherapeutics

Maksim Mamonkin

Assistant Professor

Baylor College of Medicine

Joy Aho

Senior Product Manager

Be The Match BioTherapies

Ian McNiece

CSO

Biocardia

Aura Mackenzie

Senior Director

Bluebird Bio

Robert Deans

CIO

Bluerock Therapeutics

Katie Pollock

Head of Formulation & Cryobiology

Bristol-Myers Squibb

Olivier Godeaux

CMO

Bone Therapeutics

Jean-Pierre Latere

COO

Celyad

Elizabeth Garner

Principal Scientist

Caribou Biosciences

Luis Borges

CSO

Century Therapeutics

Demetrios Kalaitzidis

Director, ImmunoOncology

CRISPR Therapeutics

Bob Valamehr

CDO

Fate Therapeutics

Oliver Nussbaumer

Head of Immunology

GammaDelta Therapeutics

Dominic Clarke

Global Head of Cell Therapy

HemaCare Corporation

Yannick Bulliard

Director, Translational Science

Immatics

Lawrence Lamb

CSO

Incysus Therapeutics

Chris Bond

VP, Cellular Engineering

Kite Pharma

Andy Snowden

Senior Director, Process Development

Kite Pharma

Marcos Langtry

Head of Allogeneic Cell Therapy Commercial Development

Lonza Pharma & Biotech

Jean-François Chaubard

CTO

MaSTheCell

Tamara Laskowski

Senior Research Scientist, Immunotherapy

MD Anderson Center

Meisam Naeimi

Postdoctoral Fellow

Nationwide Children's Hospital

Hans Klingemann

VP, R&D

NantKwest

Guanglin Yu

Senior Scientist

Novartis

Sumithira Vasu

Associate Professor

The Ohio State University

Stacey Cranert

Associate Director

Poseida Therapeutics

Chris Heery

CMO

Precision BioSciences

Dan MacLeod

Head of Cell Therapy

Precision Biosciences

Jonathan Gilbert

Head of Business Development

SQZ Biotechnologies

Chelsea Xue

Director, Head of Analytics, Cell Therapy

Takeda

Lan Cao

Senior Director, Head of Product Development & Global Program Leader, Cell Therapy

Takeda

Dario Gutierrez

VP, Discovery, Research & Innovation

TCR2 Therapeutics

Michael Leek

CEO

TCBiopharm

Bruce Bunnell

Professor & Director

Tulane University of Louisiana

Evren Alici

CEO

Vycellix

Stewart Abbot

CSO

Adicet Bio

Mark Leonard

VP, Process & Product Development Allogene Therapeutics

Mark Leonard